T cell specific loss of PTPN2 results in aggravated colitis and pronounced intestinal dysbiosis as observed in Crohn's disease patients

被引：0
|
作者：
Spalinger, M. [1 ]
Chassard, C. [2 ]
Kasper, S. [1 ]
Biedermann, L. [1 ]
Vavricka, S. [3 ]
Frey-Wagner, I. [1 ]
Atrott, K. [1 ]
Lacroix, C. [2 ]
Fried, M. [1 ,4 ]
Rogler, G. [1 ,4 ]
Scharl, M. [1 ,4 ]
机构：
[1] Univ Zurich Hosp, Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland
[2] ETH, Inst Food Nutr & Hlth, Zurich, Switzerland
[3] Hosp Triemli, Gastroenterol & Hepatol, Zurich, Switzerland
[4] Univ Zurich, Zurich Inst Human Physiol, Zurich, Switzerland
来源：
JOURNAL OF CROHNS & COLITIS | 2014年 / 8卷
关键词：
D O I：
10.1016/S1873-9946(14)60142-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P019
引用
收藏
页码：S72 / S72
页数：1
相关论文
共 50 条
  • [41] Primary non-response and loss-of-response to first-line biological therapies are more common in patients with Ulcerative Colitis than Crohn's Disease - preliminary results from the Danish IBD Biobank Project
    Zhao, M.
    Larsen, L.
    Dige, A.
    Hvas, C. L.
    Poulsen, A.
    Christiansen, D.
    Attauabi, M.
    Lo, B.
    Wewer, M.
    Ovesen, P. D.
    Petersen, A. M.
    Bendtsen, F.
    Seidelin, J. B.
    Burisch, J.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I397 - I398
  • [42] Primary non-response and loss-of-response to first-line biological therapies are more common in patients with Ulcerative Colitis than Crohn's Disease - preliminary results from the Danish IBD Biobank Project
    Zhao, M.
    Larsen, L.
    Dige, A.
    Hvas, C. L.
    Poulsen, A.
    Christiansen, D.
    Attauabi, M.
    Lo, B.
    Wewer, M.
    Ovesen, P. D.
    Petersen, A. M.
    Bendtsen, F.
    Seidelin, J. B.
    Burisch, J.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I397 - I398
  • [43] An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn's disease and experimental colitis in vivo
    Stallmach, A
    Marth, T
    Weiss, B
    Wittig, BM
    Hombach, A
    Schmidt, C
    Neurath, M
    Zeitz, M
    Zeuzem, S
    Abken, H
    GUT, 2004, 53 (03) : 339 - 345
  • [44] Anti-TNF-alpha loss of response is associated with a decreased percentage of FoxP3+ T cells and a variant NOD2 genotype in patients with Crohn’s disease
    Oriol Juanola
    Alba Moratalla
    Ana Gutiérrez
    Laura Sempere
    Pedro Zapater
    Paula Giménez
    Isabel Almenta
    Gloria Peiró
    José M. González-Navajas
    José F. Such
    Rubén Francés
    Journal of Gastroenterology, 2015, 50 : 758 - 768
  • [45] Anti-TNF-alpha loss of response is associated with a decreased percentage of FoxP3+T cells and a variant NOD2 genotype in patients with Crohn's disease
    Juanola, Oriol
    Moratalla, Alba
    Gutierrez, Ana
    Sempere, Laura
    Zapater, Pedro
    Gimenez, Paula
    Almenta, Isabel
    Peiro, Gloria
    Gonzalez-Navajas, Jose M.
    Such, Jose F.
    Frances, Ruben
    JOURNAL OF GASTROENTEROLOGY, 2015, 50 (07) : 758 - 768
  • [46] Enumeration of Th1/Th2 Polarization of CD4+T Cell Subsets in Colonic Mucosa! Lamina Propria Helps To Distinguish Between Ulcerative Colitis and Crohn's Disease
    Gui, Xianyong
    Li, Ji
    Ueno, Aito
    Luider, Joanne
    Ghosh, Subrata
    LABORATORY INVESTIGATION, 2015, 95 : 162A - 163A
  • [47] Enumeration of Th1/Th2 Polarization of CD4+T Cell Subsets in Colonic Mucosal Lamina Propria Helps To Distinguish Between Ulcerative Colitis and Crohn's Disease
    Gui, Xianyong
    Li, Ji
    Ueno, Aito
    Luider, Joanne
    Ghosh, Subrata
    MODERN PATHOLOGY, 2015, 28 : 162A - 163A
  • [48] LOSS OF TOLERANCE TO THE NOVEL GP2 ISOFORMS 1 AND 4 IS ASSOCIATED WITH BUT NOT PREDICTIVE OF CROHN'S DISEASE (CD) OF THE POUCH IN ULCERATIVE COLITIS (UC) PATIENTS AFTER ILEAL-POUCH ANAL ANASTOMOSIS (IPAA)
    Cummings, Donelle
    Lopez, Rocio
    Cruise, Michael
    Roggenbuck, Dirk
    Shen, Bo
    Rieder, Florian
    GASTROENTEROLOGY, 2017, 152 (05) : S784 - S784
  • [49] Association of Nonswitched Memory B-Cell (MBC) Levels With Ozanimod (OZA) Efficacy in Patients (Pts) With Moderately to Severely Active Crohn's Disease (CD): Results From the Phase 2 STEPSTONE Study
    Harris, Sarah
    Feagan, Brian G.
    Hanauer, Stephen B.
    Vermeire, Severine
    Ghosh, Subrata
    Yan, Jim
    Wu, Chun
    Hu, Yanhua
    Maddux, Rachel
    Wolf, Douglas C.
    D'Haens, Geert R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S867 - S868
  • [50] Infliximab Treatment Modified Immune Profile, Associating With Improved TH1/TH2 Balance and Immunoregulatory T-Cell Expression, in Immunomodulator NaIve Crohn's Disease Patients With Short Duration
    Fukunaga, Ken
    Kamikozuru, Koji
    Hida, Nobuyuki
    Ohda, Yoshio
    Yoshida, Koji
    Yokoyama, Yoko
    Kikuyama, Risa
    Kato, Kyoichi
    Takeda, Naohisa
    Nakamura, Shiro
    Miwa, Hiroto
    Matsumoto, Takayuki
    GASTROENTEROLOGY, 2010, 138 (05) : S423 - S423
12345